Bangladesh-made vaccine BANCOVID shows high efficacy in pre-clinical trial on mice: Globe Biotech

The lone Bangladeshi coronavirus vaccine developer Globe Biotech Ltd said their coronavirus vaccine --named BANCOVID-- has shown high efficacy in pre-clinical trial on mice

Oct 05, 2020
Image
a

The lone Bangladeshi coronavirus vaccine developer Globe Biotech Ltd said their coronavirus vaccine --named BANCOVID-- has shown high efficacy in pre-clinical trial on mice.

Globe Biotech Ltd now wants to start clinical trial on humans as early as possible, and is seeking cooperation from the government regulatory bodies to accelerate the approval process.

"We have completed our basic task -- the development of the vaccine. Now we want to go for a clinical trial on humans and we need approval from the regulatory bodies," Dr Kakon Nag, CEO of the company, said during his presentation at a press conference in Dhaka today.

https://www.thedailystar.net/country/news/coronavirus-vaccine-bancovid-shows-high-efficacy-pre-clinical-trial-mice-globe-biotech-1972845

Post a Comment

The content of this field is kept private and will not be shown publicly.